|
ZNF625 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.177300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.663900E-02 |
| Normal-vs-Stage2 |
8.435800E-02 |
| Normal-vs-Stage3 |
1.07610000021907E-07 |
| Normal-vs-Stage4 |
7.31879999937846E-08 |
| Stage1-vs-Stage2 |
5.472600E-01 |
| Stage1-vs-Stage3 |
1.51706999999002E-05 |
| Stage1-vs-Stage4 |
2.31629999999372E-05 |
| Stage2-vs-Stage3 |
7.695800E-02 |
| Stage2-vs-Stage4 |
3.675900E-02 |
| Stage3-vs-Stage4 |
5.216000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.610180E-04 |
| Normal-vs-AfricanAmerican |
2.285800E-02 |
| Normal-vs-Asian |
2.004000E-01 |
| Caucasian-vs-AfricanAmerican |
7.808000E-01 |
| Caucasian-vs-Asian |
6.979600E-02 |
| AfricanAmerican-vs-Asian |
8.228000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.27189999999489E-05 |
| Normal-vs-Female |
1.176120E-02 |
| Male-vs-Female |
3.156400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.025500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.757620E-02 |
| Normal-vs-Age(61-80Yrs) |
1.81570000001852E-06 |
| Normal-vs-Age(81-100Yrs) |
4.959100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.584000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.952000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.202600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.275600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.367000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.170600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.680500E-02 |
| Normal-vs-Grade 2 |
1.173250E-01 |
| Normal-vs-Grade 3 |
8.96920000048596E-07 |
| Normal-vs-Grade 4 |
1.91460181042657E-11 |
| Grade 1-vs-Grade 2 |
1.973800E-02 |
| Grade 1-vs-Grade 3 |
3.68969999997582E-06 |
| Grade 1-vs-Grade 4 |
2.06810002456592E-09 |
| Grade 2-vs-Grade 3 |
7.99920000000842E-05 |
| Grade 2-vs-Grade 4 |
2.768799634012E-10 |
| Grade 3-vs-Grade 4 |
1.563480E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.862390E-01 |
| Normal-vs-ccB subtype |
1.79082999999247E-05 |
| ccA subtype-vs-ccB subtype |
5.96789999999237E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.438900E-04 |
| Normal-vs-N1 |
1.744390E-03 |
| N0-vs-N1 |
1.579430E-01 |
|
|
